ReviewFrontiers in oncology2021
Various Uses of PD1/PD-L1 Inhibitor in Oncology: Opportunities and Challenges.
Zhitao Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
26 papers cite it
this papertrialcites it
ReviewFrontiers in oncology2021
Zhitao Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.